// App-Quantinova.ai

TCT-80 : Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

Researchers

Presenter

  • Ioanna Kosmidou

Principal Investigators

  • A. Pieter Kappetein

  • Patrick Serruys

  • Bernard Gersh

  • David Kandzari

  • Marie-Claude Morice

  • Andrzej Bochenek

  • Erick Schampaert

  • Pierre Page

  • Joseph Sabik

  • Thomas McAndrew

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, United States

  • Cardiovascular Research Foundation, New York, New York, United States

  • Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada

  • Ist Department of Cardiovascular Surgery, American Heart of Poland, Bielsko-Biała, Poland

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Mayo Clinic, Rochester, Minnesota, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Imperial College, London, United Kingdom

  • CERC, Massy, France

Locations

  • United States

  • Canada

  • Netherlands

  • France

  • United Kingdom

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved